r
maguir
consid
use
patient
decolon
aid
prevent
periop
viral
transmiss
evid
outlin
favor
recommend
approach
given
coronaviru
diseas
pandem
first
patient
reservoir
critic
factor
contribut
diseas
transmiss
must
address
evalu
impact
evidencebas
multifacet
approach
periop
staphylococcu
aureu
transmiss
surgicalsit
infect
ssi
random
clinic
trial
attent
improv
hand
hygien
patient
decolon
vascular
care
environment
clean
gener
substanti
reduct
aureu
transmiss
ssi
especi
optim
surveil
transmiss
second
povidoneiodin
chlorhexidin
broadspectrum
activ
povidoneiodin
complex
povidon
hydrogen
iodid
element
iodin
target
structur
need
surviv
replic
eg
neuraminidas
viral
propag
via
infect
noninfect
cell
hemagglutinin
attach
result
multimod
activ
povidoneiodin
rapid
effect
virucid
activ
middl
east
respiratori
syndrom
coronaviru
merscov
modifi
vaccinia
viru
ankara
mva
least
log
inactiv
pathogen
within
second
repres
antivir
potenc
alcohol
nonalcohol
hand
sanit
soap
reason
use
chlorhexidin
glucon
avail
us
peridex
oral
rins
chlorhexidin
glucon
less
effect
povidoneiodin
activ
envelop
virus
skin
oral
caviti
viral
inactiv
littl
second
inact
chlorhexidin
rins
polioviru
presum
relat
lack
envelop
viru
envelop
chlorhexidin
glucon
like
similar
activ
viru
envelop
virus
third
povidoneiodin
chlorhexidin
gargl
reduc
spread
virus
mer
outbreak
show
humantohuman
transmiss
often
involv
close
contact
health
care
arena
therefor
improv
hygien
practic
patient
decolon
help
combat
spread
povidoneiodin
prepar
reduc
viral
load
patient
skin
oropharynx
nasopharynx
agent
includ
world
health
organ
list
essenti
medicin
address
spread
viral
pathogen
global
concern
ie
hepat
influenza
mer
povidoneiodin
provid
skin
prepar
oral
gargl
formul
antiinflammatori
activ
excel
safeti
profil
resist
identifi
date
final
povidoneiodin
alcoholbas
hand
rub
effect
soapbas
hand
wash
hand
hygien
presenc
transmiss
virus
povidoneiodin
shown
prevent
spread
contagi
conjunct
fourth
nasal
povidoneiodin
formul
prevent
nasal
irrit
nasal
povidoneiodin
thicken
ph
balanc
nonirrit
sustain
effect
address
physiolog
nose
observ
issu
sneez
cough
induc
nasal
povidoneiodin
random
trial
product
well
toler
without
advers
event
author
unawar
report
suggest
otherwis
fifth
author
unawar
evid
suggest
chlorhexidin
glucon
oral
rins
associ
induc
cough
hypothet
concern
rais
dr
maguir
balanc
substanti
evid
oral
reservoir
contain
high
viral
load
attenu
prevent
spread
chlorhexidin
glucon
may
use
achiev
goal
whether
altern
povidoneiodin
oral
rins
effect
current
unkn
conclus
evid
show
favor
riskbenefit
profil
recommend
patient
decolon
nasal
povidon
oral
chlorhexidin
rins
help
mitig
periop
spread
substanti
concern
remain
eg
sneez
andor
cough
would
recommend
use
agent
patient
induct
stabil
given
sever
pandem
believ
would
illadvis
avoid
use
evidencebas
prevent
measur
step
part
comprehens
program
stand
solid
bodi
publish
evid
establish
past
year
respons
periop
defens
fund
origin
studi
fund
part
anesthesia
patient
safeti
foundat
depart
anesthesia
univers
iowa
complet
letter
fund
depart
anesthesia
conflict
interest
r
w
loftu
report
research
fund
sage
medic
inc
bbraun
draeger
kenal
one
patent
pend
partner
rdb
bioinformat
llc
n
st
omaha
ne
compani
own
pathtrac
spoken
educ
meet
sponsor
kenal
aorn
bbraun
apic
c
parra
affili
rdb
bioinformat
llc
r
w
loftu
spous
remain
author
declar
conflict
interest
